A United States district court judge in Dallas granted Houston-based Global Tel * Link’s request to stop the proceedings of a patent infringement case filed against the company by Securus Technologies, Inc., according to PR Newswire on July 2.
The PTO is investigating the validity of the three patents because GTL challenged the validity of the three Securus patents in 2014 under new American Invention Act procedures. According to PTO’s preliminary investigations, there is “reasonable likelihood” that these patents should not have been issued.
The Dallas attorneys at Gagnon, Peacock & Vereeke, P.C., are dedicated to representing people throughout intellectual property law legal disputes. If you are in this situation, call our team at (214) 824-1414 today to learn more.
The United States Supreme Court is at a standstill as it reviews a case that pits pharmaceutical companies against each other over ownership of the world’s best-selling multiple sclerosis drug, an Associated Press article reported on October 15.
Israel-based Teva Pharmaceutical Industries, Ltd., which distributes $4 billion annually of the drug known as Copaxone, presented its arguments on October 15. According to Teva, the U.S. Court of Appeals for the Federal Circuit made a mistake when it overturned five of its patents for Copaxone. The current point of contention is the issue of whether the appeals court has the capacity to go against factual findings made by a federal district court that earlier approved the patents.
Our legal team at Gagnon, Peacock & Vereeke, P.C., has ample experience when it comes to providing aggressive legal representation to clients involved in intellectual property cases in Dallas, Fort Worth or other areas in Texas. Call our offices today at (214) 824-1414 to set up an appointment.
CopyTele Inc.’s subsidiary, Encrypted Cellular Communications Corp. (EC3) recently filed a patent infringement lawsuit against multinational telecommunications corporation AT&T Inc. in the U.S. District Court for the Northern District of Texas, Dallas Division, AG-IP News reported on May 7.
The lawsuit is the sixth filed by CTI regarding patent assertion since January, when they implemented their new business model. CTI is claiming that AT&T is using its encrypted cellular communications technology for profit, billing its customers a one-time activation fee of $115 per device and requiring monthly charges of $39.99, on top of data and wireless charges.
According to a 2012 University of California in Berkeley report, telecommunication companies will take advantage of the fact that encryption technology systems are becoming more in demand by charging incremental activation fees and service charges, not to mention declaring higher prices for encryption-based hardware and software.
CTI upholds inventors’ rights through patent monetization and patent assertion.
Consult with our attorneys at Gagnon, Peacock & Vereeke, P.C. in Dallas and Fort Worth for legal advice regarding intellectual property rights, patents, trademarks, and the like. Call our offices today at (214) 824-1414 or 888-312-1750.